Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Harvard Apparatus Regenerative Technology Inc. (OTC : HRGN) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Harvard Apparatus Regenerative Technology Inc., a clinical-stage biotechnology company, engages in developing regenerative-medicine treatments for disorders of the gastro-intestinal system and the airway resulting from cancer, trauma, or birth defects. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Biostage, Inc. and changed its name to Harvard Apparatus Regenerative Technology Inc. in July 2023. Harvard Apparatus Regenerative Technology Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
Quote
| Last: | $1.155 |
|---|---|
| Change Percent: | 3.12% |
| Open: | $1.155 |
| Close: | $1.12 |
| High: | $1.155 |
| Low: | $1.155 |
| Volume: | 100 |
| Last Trade Date Time: | 06/04/2026 11:14:00 am |
Stock Data
| Market Cap: | $30,389,093 |
|---|---|
| Float: | 7,068,026 |
| Insiders Ownership: | 1.63% |
| Institutions: | 1 |
| Short Percent: | 121658% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.biostage.com |
| Country: | US |
| City: | Holliston |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Harvard Apparatus Regenerative Technology Inc. (OTC: HRGN).
